Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 91, Issue 1, Pages 151-167
Publisher
IOS Press
Online
2022-11-18
DOI
10.3233/jad-220471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of a Potential Synergistic Effect of Souvenaid ® in Mild Alzheimer’s Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study
- (2021) Félix Viñuela et al. JOURNAL OF ALZHEIMERS DISEASE
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Alzheimer disease
- (2021) David S. Knopman et al. Nature Reviews Disease Primers
- Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study
- (2021) Van Thu Nguyen et al. BMC Medicine
- Alzheimer’s Treatment: Real-World Physician Behavior Across Countries
- (2020) Jana Podhorna et al. ADVANCES IN THERAPY
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
- (2020) Mhairi Campbell et al. BMJ-British Medical Journal
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
- (2020) Zahinoor Ismail et al. Alzheimers & Dementia
- Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study
- (2020) Jing Yuan et al. JOURNAL OF ALZHEIMERS DISEASE
- How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
- (2019) Stéphane Epelbaum et al. BMJ Open
- Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
- (2019) Daniela Bertens et al. Alzheimers Research & Therapy
- A Real-World Evidence Analysis of Associations Among Costs, Quality of Life, and Disease-Severity Indicators of Alzheimer’s Disease in Thailand
- (2019) Khachen Kongpakwattana et al. VALUE IN HEALTH
- Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
- (2018) Catherine Reed et al. Alzheimers Research & Therapy
- The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings
- (2018) Anders Wimo et al. JOURNAL OF ALZHEIMERS DISEASE
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- PND16 - PHARMACEUTICAL TREATMENT OF MILD ALZHEIMER’S DISEASE IN GERMANY – RESULTS FROM A DELPHI PANEL
- (2018) KM Kohlscheen et al. VALUE IN HEALTH
- Use of antidementia drugs in German patients with Alzheimer’s disease
- (2017) Philipp Hessmann et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study
- (2017) Javier Olazarán et al. INTERNATIONAL PSYCHOGERIATRICS
- Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
- (2017) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Practice guideline update summary: Mild cognitive impairment
- (2017) Ronald C. Petersen et al. NEUROLOGY
- Comparison of neuropsychological and functional outcomes in Alzheimer's disease patients with good or bad response to a cognitive stimulation treatment: a retrospective analysis
- (2016) Mar Martínez-Moreno et al. INTERNATIONAL PSYCHOGERIATRICS
- PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
- (2016) Jessie McGowan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease
- (2016) Lilah M. Besser et al. PARKINSONISM & RELATED DISORDERS
- Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
- (2016) Carina Wattmo et al. Alzheimers Research & Therapy
- Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease
- (2015) Erika Droogsma et al. INTERNATIONAL PSYCHOGERIATRICS
- The Effect of APOE ε4 Allele on Cholinesterase Inhibitors in Patients With Alzheimer Disease
- (2013) Liang Wang et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- Alzheimer’s Disease Management Guideline: Update 2008
- (2011) Freddi Segal-Gidan et al. Alzheimers & Dementia
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- Cross Sectional Observational Study on the Societal Costs of Alzheimers Disease
- (2010) J. Mesterton et al. Current Alzheimer Research
- EFNS guidelines for the diagnosis and management of Alzheimer’s disease
- (2010) J. Hort et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimerʼs Disease
- (2009) Pai-Yi Chiu et al. CLINICAL DRUG INVESTIGATION
- Alzheimer's disease neuropathologic changes in semantic dementia
- (2009) Tiffany W. Chow et al. NEUROCASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now